Profil
Ryan D.
Maynard is currently an Independent Director at Iovance Biotherapeutics, Inc. since 2015 and Chief Financial & Accounting Officer at Foghorn Therapeutics, Inc. starting in 2026.
Former roles include Chief Financial Officer at CARA Therapeutics, Inc. from 2022 to 2025; Chief Financial Officer at LetsGetChecked, Inc. from 2019 to 2022; Chief Financial Officer at Blade Therapeutics, Inc. from 2018 to 2019; CFO, Executive VP & Head-Investor Relations at Rigel Pharmaceuticals, Inc. from 2011 to 2017; Controller, Director-Finance & Accounting at Personify, Inc. (California) in 2001; Controller at General Magic, Inc. from 1998 to 1999; Senior Manager-Finance at Siliconix, Inc. from 1994 to 1998; and Chief Financial Officer at Paulus.
(Holdings) Ltd. Education includes undergraduate studies at Santa Clara University.
Postes actifs de Ryan Maynard
| Sociétés | Poste | Début |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/02/2015 |
| FOGHORN THERAPEUTICS INC. | Directeur Financier/CFO | 23/02/2026 |
Anciens postes connus de Ryan Maynard
| Sociétés | Poste | Fin |
|---|---|---|
| CARA THERAPEUTICS, INC. | Directeur Financier/CFO | 01/04/2025 |
LetsGetChecked, Inc.
LetsGetChecked, Inc. Packaged SoftwareTechnology Services Operates as an online health test start-up for genetic testing services | Directeur Financier/CFO | 01/03/2022 |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Directeur Financier/CFO | 01/06/2019 |
| RIGEL PHARMACEUTICALS, INC. | Directeur Financier/CFO | 31/12/2017 |
Personify, Inc. (California)
Personify, Inc. (California) Packaged SoftwareTechnology Services Manufactures e-Business analytics software | Directeur Financier/CFO | 01/04/2001 |
Formation de Ryan Maynard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Siliconix, Inc.
Siliconix, Inc. SemiconductorsElectronic Technology Manufactures semiconductor and switches | Electronic Technology |
General Magic, Inc.
General Magic, Inc. Information Technology ServicesTechnology Services Develops integrated telephony and Web applications | Technology Services |
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Personify, Inc. (California)
Personify, Inc. (California) Packaged SoftwareTechnology Services Manufactures e-Business analytics software | Technology Services |
CARA Therapeutics, Inc.
CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Foghorn Therapeutics, Inc.
Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
LetsGetChecked, Inc.
LetsGetChecked, Inc. Packaged SoftwareTechnology Services Operates as an online health test start-up for genetic testing services | Technology Services |
Paulus (Holdings) Ltd.
Paulus (Holdings) Ltd. Financial ConglomeratesFinance Operates as an investment company | Finance |
















